Moderna awarded tender for COVID-19 vaccine
Moderna Receives EU Tender Order for Covid-19 Vaccine
Moderna on Friday said it received approval for supplying its Spikevax Covid-19 vaccine to the European Union, Norway and North Macedonia following a tender process. Under the agreement, 17 participating countries could order an updated version of the biotech company's mRNA Covid-19 vaccine for up to four years.
The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.
Traditional vaccines typically focus on the most accessible parts of viruses, which are often the rapidly mutating ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.
Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...
We're learning more about a massive artificial intelligence infrastructure bill announced Tuesday by President Donald Trump.
Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback